Author:
Gaisa Nadine Therese,Hartmann Arndt,Knüchel-Clarke Ruth
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. WHO Classification of Tumours Editorial Board (2022) Urinary and male genital tumours [Internet]. Lyon (France): International Agency for Research on Cancer. https://tumourclassification.iarc.who.int/chapters/36. Zugegriffen: 7. Juli 2022 (WHO classification of tumours series, 5th ed.; vol. 8)
2. van der Kwast T, Liedberg F, Black PC, Kamat A, van Rhijn BWG, Algaba F, Berman DM, Hartmann A, Lopez-Beltran A, Samaratunga H, Varma M, Cheng L (2022) International society of urological pathology expert opinion on grading of urothelial carcinoma. Eur Urol Focus 8(2):438–446. https://doi.org/10.1016/j.euf.2021.03.017
3. https://www.awmf.org/uploads/tx_szleitlinien/032-038OLl_S3_Harnblasenkarzinom_2020-04-verlaengert.pdf. Zugegriffen: 17. Juli 2022
4. Bertz S, Denzinger S, Otto W, Wieland WF, Stoehr R, Hofstaedter F, Hartmann A (2011) Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer—evaluation of a large hospital-based single-centre series. Histopathology 59(4):722–732. https://doi.org/10.1111/j.1365-2559.2011.03989.x
5. Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE (1984) Malignant urachal lesions. J Urol 131(1):1–8. https://doi.org/10.1016/s0022-5347(17)50167-6